(TRSY) Xtrackers US 0-1 Year - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • • Short Government
The underlying index is designed to track the performance of certain U.S. Treasury securities that have a remaining maturity between one month and one year. The fund will invest at least 80% of its total assets (but typically far more) in component securities of the underlying index.
Additional Sources for TRSY ETF
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
TRSY ETF Overview
Market Cap in USD | 33m |
Category | Short Government |
IPO / Inception | 2024-10-08 |
TRSY ETF Ratings
Growth Rating | 23.8 |
Fundamental | - |
Dividend Rating | 28.9 |
Rel. Strength | 9.9 |
Analysts | - |
Fair Price Momentum | 28.80 USD |
Fair Price DCF | - |
TRSY Dividends
Dividend Yield 12m | 2.22% |
Yield on Cost 5y | 2.27% |
Annual Growth 5y | 14.21% |
Payout Consistency | 100.0% |
TRSY Growth Ratios
Growth Correlation 3m | 95.8% |
Growth Correlation 12m | 99.5% |
Growth Correlation 5y | 99.5% |
CAGR 5y | 2.63% |
CAGR/Max DD 5y | 0.00 |
Sharpe Ratio 12m | -1.44 |
Alpha | -1.55 |
Beta | -0.002 |
Volatility | 0.49% |
Current Volume | 10.9k |
Average Volume 20d | 5.9k |
What is the price of TRSY stocks?
As of May 20, 2025, the stock is trading at USD 30.12 with a total of 10,864 shares traded.
Over the past week, the price has changed by +0.07%, over one month by +0.23%, over three months by +1.09% and over the past year by +2.63%.
As of May 20, 2025, the stock is trading at USD 30.12 with a total of 10,864 shares traded.
Over the past week, the price has changed by +0.07%, over one month by +0.23%, over three months by +1.09% and over the past year by +2.63%.
Is Xtrackers US 0-1 Year a good stock to buy?
Neither. Based on ValueRay Analyses, Xtrackers US 0-1 Year is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 23.78 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TRSY as of May 2025 is 28.80. This means that TRSY is currently overvalued and has a potential downside of -4.38%.
Neither. Based on ValueRay Analyses, Xtrackers US 0-1 Year is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 23.78 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TRSY as of May 2025 is 28.80. This means that TRSY is currently overvalued and has a potential downside of -4.38%.
Is TRSY a buy, sell or hold?
Xtrackers US 0-1 Year has no consensus analysts rating.
Xtrackers US 0-1 Year has no consensus analysts rating.
What are the forecast for TRSY stock price target?
According to ValueRays Forecast Model, TRSY Xtrackers US 0-1 Year will be worth about 31.1 in May 2026. The stock is currently trading at 30.12. This means that the stock has a potential upside of +3.25%.
According to ValueRays Forecast Model, TRSY Xtrackers US 0-1 Year will be worth about 31.1 in May 2026. The stock is currently trading at 30.12. This means that the stock has a potential upside of +3.25%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 31.1 | 3.3% |